FMP

FMP

Enter

INBX - Inhibrx Bi...

photo-url-https://images.financialmodelingprep.com/symbol/INBX.png

Inhibrx Biosciences, Inc.

INBX

NASDAQ

Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions. Its therapeutic candidates includes INBRX-109, a tetravalent therapeutic candidate targeting death-receptor 5 that is in phase 2 clinical trial for the treatment of unresectable or metastatic conventional chondrosarcoma; and INBRX-106, a hexavalent sdAb-based therapeutic candidate targeting OX4 that is in phase 2 clinical trial for the treatment of metastatic solid tumor, non-small cell lung cancer, melanoma, head and neck cancer, gastric (GIST) and gastroesophageal adenocarcinoma (GEA) cancer, renal cell carcinoma, and urothelial (transitional) cell carcinoma. The company was incorporated in 2024 and is based in La Jolla, California.

14.1 USD

-0.05 (-0.355%)

Build Up Free Cash Flow

Year

2020

2021

2022

2023

2024

2025

2026

2027

2028

2029

Revenue

2.76B

1.76B

1.57B

1.39B

1.38B

1.18B

1B

853.43M

727.07M

619.42M

Operating Cash Flow

134.53M

19.82M

-133.01M

76.93M

62.37M

17.84M

15.2M

12.95M

11.03M

9.4M

Cap Ex

-33.71M

-36.27M

-27.65M

-23.55M

-23.6M

-19.87M

-16.93M

-14.42M

-12.29M

-10.47M

Free Cash Flow

100.82M

-16.45M

-160.66M

53.38M

38.77M

-2.03M

-1.73M

-1.47M

-1.26M

-1.07M

Wacc

9.25

9.25

9.25

9.25

9.25

Pv Lfcf

-1.86M

-1.45M

-1.13M

-881.81k

-687.64k

Sum Pv Lfcf

-6.01M

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedin
2017-2024 © Financial Modeling Prep